PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Feb-2024 Global Flexible Industrial Packaging Market Outlook 2023-2036: Plastic Material Dominates, Rising Demand for Sustainable Packaging Driving Growth - ResearchAndMarkets.com Businesswire
07-Feb-2024 Moderna Chief Executive Officer Stéphane Bancel Elected to National Academy of Engineering AccessWire
07-Feb-2024 Delta-Fly Pharma Inc.: Abstracts submission for Phase I Clinical Trial of DFP-14927 to 2024 ASCO annual meeting Businesswire
07-Feb-2024 Watson-Marlow Fluid Technology Solutions to Showcase Fluid Path Product Range at ISPE Rocky Mountain and ISPE CaSA   Sciad Newswire
07-Feb-2024 ATS Reports Third Quarter Fiscal 2024 Results Businesswire
07-Feb-2024 Invitation to Presentation of Cantargia’s Year-End Report 2023 on February 22 at 3.00 p.m. CET AccessWire
07-Feb-2024 Tribun Health Clinches Best in KLAS Award for the Third Consecutive Year AccessWire
07-Feb-2024 Phoreus Biotech Appoints David Schaefer as CEO to Lead Development of Innovative Drug Delivery Nanocarriers AccessWire
07-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
07-Feb-2024 Senzime Licensee Fukuda Denshi Launches Integrated TetraGraph Module in Japanese Market AccessWire
07-Feb-2024 Two Labs Launches Sunshine Transparency and Aggregate Spend Offering to Provide Transparency Reporting and Compliance Support to the Pharma Industry Newswire
07-Feb-2024 InfinityRx Appoints Kevin Wong as Chief Technology Officer Newswire
07-Feb-2024 InfinityRx Appoints Kevin Wong as Chief Technology Officer AccessWire
07-Feb-2024 Two Labs Launches Sunshine Transparency and Aggregate Spend Offering to Provide Transparency Reporting and Compliance Support to the Pharma Industry AccessWire
07-Feb-2024 JT Group Recognized on CDP’s Climate Change A List and Water Security A List Businesswire
07-Feb-2024 MultiOmic Health and Queen’s University Belfast join forces to transform diabetic kidney disease diagnosis MultiOmic Health
07-Feb-2024 OncoZenge Files Patent Application for Strengthened IP Protection for BupiZenge™ OncoZenge AB
07-Feb-2024 TRIAL OF NEW PSYCHEDELIC DRUG SEEKS PATIENTS WITH TREATMENT RESISTANT DEPRESSION Clerkenwell Health
07-Feb-2024 HUTCHMED Highlights Presentation of Phase III Data on Fruquintinib in Second-Line Gastric Cancer at ASCO Plenary Series Session HUTCHMED
07-Feb-2024 Invizius Treats First Patients in First-In-Human Phase 1 Clinical Study of Lead Dialysis Product H-Guard® Invizius